Evidence map›Paper›PMID 40965078›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2026

Low Cholesterol Associated With TB in People Living With HIV in an Asia-Pacific Cohort.

Rebecca T Henry, Vohith Khol, Cuong Duy, Ivan Marbaniang, I Ketut Agus Somia, Nagalingeswaran Kumarasamy, Evy Yunihastuti, Iskandar Azwa, Rossana Ditangco, Sasisopin Kiertiburanakul and 14 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Rebecca T HenryThe Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.ORCID 0000-0003-4567-5960
Vohith KholNational Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Cuong DuyBach Mai Hospital, Hanoi, Vietnam.ORCID 0000-0002-1130-8006
Ivan MarbaniangBJ Government Medical College and Sassoon General Hospital, Pune, India.ORCID 0000-0002-8446-9943
I Ketut Agus SomiaFaculty of Medicine Udayana University, Ngoerah Hospital, Bali, Indonesia.ORCID 0000-0001-6339-3401
Nagalingeswaran KumarasamyVHS-Infectious Diseases Medical Centre, Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), Voluntary Health Services, Chennai, India.ORCID 0009-0006-2252-5731
Evy YunihastutiFaculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.ORCID 0000-0001-6650-0559
Iskandar AzwaUniversity Malaya Medical Centre, Kuala Lumpur, Malaysia.ORCID 0000-0003-1977-6709
Rossana DitangcoResearch Institute for Tropical Medicine, Muntinlupa City, Philippines.ORCID 0009-0008-6105-2249
Sasisopin KiertiburanakulFaculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0003-4379-4704
Man Po LeeQueen Elizabeth Hospital, Hong Kong SAR.
Anchalee AvihingsanonHIV-NAT/Thai Red Cross AIDS and Infectious Diseases Research Centre and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0003-3222-9611
Hsin Pai ChenTaipei Veterans General Hospital, Taipei, Taiwan.
Romanee ChaiwarithFaculty of Medicine and Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0002-1241-5954
Suwimon KhusuwanChiangrai Prachanukroh Hospital, Chiang Rai, Thailand.ORCID 0000-0001-6975-057
Thach Ngoc PhamNational Hospital for Tropical Diseases, Hanoi, Vietnam.
Sanjay PujariInstitute of Infectious Diseases, Pune, India.
Chiaw Yee ChoyTan Tock Seng Hospital, National Centre for Infectious Diseases, Singapore.ORCID 0000-0003-2658-2996
Jun Yong ChoiDivision of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.ORCID 0000-0002-2775-3315
Yasmin GaniHospital Sungai Buloh, Sungai Buloh, Malaysia.
Haruka UemuraNational Center for Global Health and Medicine, Tokyo, Japan; and.ORCID 0000-0002-2096-8620
Jeremy RossTREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand .ORCID 0000-0003-3183-2451
Awachana JiamsakulThe Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.ORCID 0000-0003-4810-0783
IeDEA Asia-Pacific

Funding

The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
NIAID NIH HHS U01 AI069907
6 · The paper itself

Abstract

backgroundTuberculosis (TB) remains the leading cause of illness and death among people living with HIV (PLHIV), particularly in high-burden areas. This study examined associations between TB and routine clinical markers: serum cholesterol, platelet count, and CD4 cell count.

settingThe analysis included data from the TREAT Asia HIV Observational Database, a multicenter cohort of adult PLHIV receiving care across the Asia-Pacific region.

methodsThe authors conducted a cross-sectional matched case-control study of prospective and retrospective patients with TB, comparing clinical and laboratory data within ±3 months of TB diagnosis. Conditional logistic regression assessed associations between TB and covariates.

resultsThe analysis included 4244 PLHIV from 20 sites: 1427 patients with TB and 2817 matched controls. Patients with TB were predominantly male (75.3%) and 45.7% aged 31-40 years. Multivariable analysis showed greater odds of TB diagnosis among males, those with low BMI, prior AIDS diagnosis, high HIV viral load, low CD4 + counts, or low total cholesterol. CD4 + counts <200 cells/μL had higher TB odds (adjusted OR [aOR] 12.90, 95% CI: 8.84-18.82) than CD4 + >500 cells/μL. Cholesterol <3.9 mmol/L had higher TB odds (aOR 3.11, 95% CI: 1.94 to 4.98) than cholesterol >5.5 mmol/L.

conclusionsIn this Asia-Pacific cohort of adults living with HIV, low CD4 + cell count and low total serum cholesterol were associated with increased TB odds. Cholesterol may represent a low-cost adjunct marker to support TB risk stratification in PLHIV in endemic settings, but requires validation and evaluation of feasibility and cost-effectiveness.

Indexed as

CholesterolHIV InfectionsTuberculosisAdultAsiaCase-Control StudiesCD4 Lymphocyte CountCross-Sectional StudiesFemaleHumansMaleMiddle AgedProspective StudiesRetrospective StudiesCholesterolcase–control studiesCD4 lymphocyte countcholesterolhuman immunodeficiency virusodds ratiotuberculosis

Identifiers

PMID40965078
PMCPMC12537004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.